Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/73098
Title: | 臺灣兒童用藥安全與醫師開立處方行為之評估:系統動態學之觀點 Evaluating Pediatric Drug Safety and Prescribing Behavior in Taiwan:A System Dynamics Approach |
Authors: | Yi-Rou Lei 雷沂柔 |
Advisor: | 余峻瑜(Jiun-Yu Yu) |
Keyword: | 系統動態學,兒童用藥安全,醫師開方行為,小兒磨粉,兒童專用藥, System Dynamics,Pediatric Drug Safety,Pulverized Medicine,Prescribing Behavior,Pediatric Drug Formulation, |
Publication Year : | 2019 |
Degree: | 碩士 |
Abstract: | Drug formulation used in pediatric patients should be appropriate, safe, as well as be adapted to children’s needs. The use of inadequate drug formulation and the pulverizing medicine phenomenon are widespread in Taiwan. Many existing treatments are not suitable for children, which often leads to medical malpractice. Although the advocacy of pediatric drug safety from non-government organization, the improving regulations from government regarding current clinical situations remain stagnant. In order to evaluate the pediatric drug safety issue, this essay uses system dynamics approach to analyze the results that come from different prescribing behaviors. The analyses found out problems generated from pulverized medicine caused drug safety, drug efficacy, and cost issues, causing the decrease of the relative safety and efficacy of treatment, illustrated by balancing loops in the system dynamics. On the other hand, the reinforcing loops in the system dynamics generated from pediatric drug formulations created incentives to drive doctors to prescribe more pediatric drug formulations, leading to better drug safety and drug efficacy of treatment for children. Therefore, the system dynamics depicts the whole structure of pediatric drug safety issue came from different prescribing behaviors, letting us have a clear picture to address this problem. Four key issues that need to be addressed to stimulate the further improvement for pediatric drug safety in the medical system are identified: (1) building the network of medical institutions to promote pediatric safety; (2) set up online platforms and use of existing data to transmit more medication knowledge; (3) collect more clinical feedback and patients’ outcome to improve the development and the utilization of pediatric drug formulation (4) take the responsibility of saving more medical resources, helping government to save the cost in order to address drug safety and many other issues. |
URI: | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/73098 |
DOI: | 10.6342/NTU201901332 |
Fulltext Rights: | 有償授權 |
Appears in Collections: | 管理學院企業管理專班(Global MBA) |
Files in This Item:
File | Size | Format | |
---|---|---|---|
ntu-108-1.pdf Restricted Access | 4.07 MB | Adobe PDF |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.